Personal Information

Gen-Min Lin, M.D., M.P.H

Director of Division of Cardiology, Hualien-Armed Forces General Hospital.

 

Research Interests

Clinical trials

Epidemiology in cardiovascular disease

Inflammation, metabolic syndrome and cardiovascular disease

Infective endocarditis and ischemic stroke

Antiplatelet therapy and coronary revascularization for acute myocardial infarction

Biomarker and heart failure

Exercise and cardiac rehabilitation

Hypertension and acute kidney injury

 

Publications

  1. Chang CC, Chang ST*, Chang HY, Lin GM, Lai MH, Chiang SL. Multicentric giant cell tumours in an adolescent with haemophilia. Haemophilia. 2007 Mar;13(2):199-201 (Case Report) (SCI: IF:2.6)
  2. Lin GM, Chao TY, Wang WB*. Acute coronary syndromes and Anagrelide. Int J Cardiol. 2007 Apr 12;117(1):e17-9. (Letter) (SCI: IF: 7.1)
  3. Lin GM, Chu KM, Juan CJ, Chang FY*. Cerebral hemorrhage in infective endocarditis caused by Actinobacillus actinomycetemcomitans. Am J Med Sci. 2007 Nov;334(5):389-92.(Case Report) (SCI: IF:1.4)
  4. Lin GM, Lin JC, Chen PJ, Siu LK, Huang LY, Chang FY*. Pan-drug resistant Acinetobacter baumannii bacteremia following endoscopic retrograde cholangiopancreatography. Am J Gastroenterol. 2008 Feb;103(2):498-9. (Letter) (SCI: IF: 7.3)
  5. Wang WB, Lin GM*. Pseudocoarctation and coarctation. Int J Cardiol. 2009 Apr 3;133(2):e62-4. (SCI: IF: 7.1)
  6. Lin WY, Lin GM, Chang FY*. An unusual presentation of scrub typhus with atraumatic hemoperitoneum. Am J Gastroenterol. 2009 Apr;104(4):1067.(Letter) (SCI: IF:7.3)
  7. Lin GM*, Han CL. Bone pain as an atypical early manifestation of acute myocardial infarction. Am J Emerg Med. 2009 Sep;27(7):894-5. (letter) (SCI: IF: 2.0)
  8. Lin WY, Lin GM, Wu CC*. Coexistence of non-communicated chylothorax and chylous ascites in nephrotic syndrome. Nephrology (Carlton). 2009 Oct;14(7):700. (Case Report) (SCI: IF: 1.3)
  9. Kan LP, Chu KM, Lin GM*. Letter by Kan et al regarding article. “Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial.” Circulation. 2009 Nov;120:e164. (Letter) (SCI: IF: 14.7)
  10. Lin GM, Sun LW, Lin CS, Chu KM, Tzeng BH*. Effects of Coronary Intervention on Cardiopulmonary Exercise Testing in Men with Stable Coronary Artery Disease – A Pilot Observation. Acta Cardiologica Sinica 2009 Dec; 25:190-200 (Original article) (SCI: IF:0.6)
  11. Chou CH, Lin GM, Ku CH, Chang FY*. Comparison of APACHE II, GCS and MRC in predicting outcomes in patients with tuberculous meningitis. Int J Tuberc Lung Dis 2010 Jan; 14: 86-92 (Original article) (SCI: IF:2.7)
  12. Lin GM*, Chu KM, Han CL. Letter by Lin et al regarding article. “Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.” Circulation. 2010 Mar;121:e43. (Letter) (SCI: IF: 14.7)
  13. Lin GM*, Han CL. The loading dose of clopidogrel in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty. Am J Emerg Med. 2010 Mar;28:382-3 (Letter) (SCI: IF: 2.0)
  14. Lin GM*, Han CL. Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials. Eur Heart J. 2010 Mar; 31:753-4. (Letter) (SCI: IF: 10.4)
  15. Lin GM*, Chu KM, Han CL. Letter by Lin et al regarding article. “Heart Rate Predicts Outcomes in an Implantable Cardioverter-Defibrillator Population.” Circulation. 2010 Jun 22;121(24):e450 (letter) (SCI: IF: 14.7)
  16. Lin GM*, Chu KM, Han CL. Triple antiplatelet therapy reduces ischemic events after drug-eluting stent implantation: Drug-Eluting stenting followed by Cilostazol treatment REduces Adverse Serious cardiac Events (DECREASE registry). Am Heart J. 2010 Sep;160(3):e21 (letter) (SCI: IF: 4.7)
  17. Lin GM*, Han CL. Letter regarding bradyarrhythmia caused by ginseng in a patient with chronic kidney disease. Am J Emerg Med. 2010 Oct;28(8):978 (letter) (SCI: IF: 2.0)
  18. Lin GM*, Chu KM, Han CL. Reverse epidemiology reflects C-reactive protein as a bystander of atherosclerosis in established systemic inflammation models. Int J Cardiol. 2011 Feb 3;146(3):422-3. (SCI: IF: 7.1)
  19. Lin GM*, Chu KM, Han CL. The influence of inflammation outweighing the metabolic syndrome on cardiovascular risk and mortality. Int J Cardiol. 2011 Feb 3;146(3):431. (SCI: IF: 7.1)
  20. Lin GM*, Chu KM, Han CL. Elective intra-aortic balloon pump placement in high-risk percutaneous coronary intervention. JAMA. 2010 Nov 24;304(20):2240 (SCI: IF: 30.0)
  21. Lin GM*, Chu KM, Han CL. Pexelizumab may be hazardous to those with ST-segment elevation myocardial infarction undergoing primary percutaneous interventions without using glycoprotein IIb-IIIa inhibitors. Int J Cardiol. 2011;146(2):280-2. (SCI: IF: 7.1)
  22. Lin GM*, Han CL.Letter regarding rapidly improving, severe acute myocarditis after a scorpion bite. Am J Emerg Med. 2011;29(3):346-7 (SCI: IF: 2.0)
  23. Lin GM*, Li YH, Wen SH, Chen SY, Chu KM, Han CL. Predictors, moderators and mediators for the effectiveness of pexelizumab treatment in patients undergoing primary coronary revascularization. Int J Cardiol. 2011; 147(2):340-1. (SCI: IF: 7.1)
  24. Chen YG, Lin TY, Lin GM, Lin JC. Pulmonary cryptococcus infection after mono-chemotherapy with gemcitabine. Respir Care. 2011; 56(3):339-41 (SCI: IF: 2.0)
  25. Lin GM*, Li YH, Chu KM, Han CL. A single level of plasma troponin-I predicts left ventricular remodelling after primary angioplasty. Heart. 2011;97(4):340-1 (SCI: IF: 4.2)
  26. Lin GM*, Li YH, Han CL. Letter for Killip classification and glucose level in patients with acute myocardial infarction. Am J Emerg Med. 2011; 29(4):462  (SCI: IF: 2.0)
  27. Lin GM*, Li YH. Comparison of 600 versus 300-mg clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary coronary angioplasty. Am J Cardiol. 2011;107(4):641. (SCI: IF: 3.7)
  28. Lin GM*, Li YH. Usefulness of serial of B-type natriuretic peptide and troponin-I levels to predict left ventricular remodeling after primary coronary angioplasty. Am J Cardiol. 2011;107(5):797-8. (SCI: IF: 3.7)
  29. Lin GM*, Li YH, Wen SH. Aerobic and resistance training for patients with type 2 diabetes. JAMA. 2011; 305(9):891 (SCI: IF: 30.0)
  30. Lin GM*, Chu KM, Han CL. Letter by Lin et al regarding article, "Acute kidney injury and cardiovascular outcomes in acute severe hypertension". Circulation. 2011;123(9):e267 (SCI: IF: 14.7)
  31. Lin GM*, Li YH, Chu KM, Han CL. What else does the JUPITER trial add regarding C-reactive protein and cardiovascular disease? Int J Cardiol. 2011 Jun 16;149(3):387 (SCI: IF: 7.1)
  32. Lin GM*, Li YH, Chu KM, Han CL. Hyponatremia may reflect malnutrition in patients with acute pulmonary embolism. Am J Respir Crit Care Med. 2011;183(6):827 (SCI: IF: 11.0)
  33. Lin GM*, Li YH, Chu KM, Han CL. Longitudinal mechanics of the periinfarct zone and ventricular tachycardia inducibility in patients with chronic ischemic cardiomyopathy. Am Heart J. 2011;161(4):e17 (SCI: IF: 4.7)
  34. Lin GM*, Li YH, Chu KM, Han CL. Prevalence and characteristics of patients with clinical improvement but not significant left ventricular reverse remodeling after cardiac resynchronization therapy. Am Heart J. 2011;161(4):e21 (SCI: IF: 4.7)
  35. Lin GM*,Chu KM, Han CL. Letter by Lin et al regarding article, "Hepatitis C virus infection and increased risk of cerebrovascular disease". Stroke. 2011 Jun;42(6):e389 (SCI: IF: 5.2)
  36. Lin GM*, Li YH, Chu KM, Han CL. Controversies with On-TIME 2. Heart. 2011;97(12):1026 (SCI: IF: 4.2)
  37. Lin GM*, Li YH, Chu KM, Han CL. Malnutrition and hyponatremia in dialysis patients. Am J Med. 2011;124(8):e21 (SCI: IF: 5.4)
  38. Lin GM*, Li YH, Chu KM, Han CL. Clopidogrel loading dose in patients undergoing elective percutaneous coronary intervention. Heart. 2011;97(13):1111 (SCI: IF: 4.2)
  39. Lin GM*. Anticoagulation in patients with stroke with infective endocarditis. Int J Cardiol. 2011;151(2):246. (SCI: IF: 7.1)
  40. Lin GM*.. C-reactive protein, smoking and the metabolic syndrome. Int J Cardiol. 2011;151(3):373-4. (SCI: IF: 7.1)
  41. Lin GM*, Li YH, Chu KM, Han CL. Standard versus high loading doses of clopidogrel in Asian patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: insights from the Korea Acute Myocardial Infarction Registry. Am Heart J. 2011;162(1):e17 (SCI: IF: 4.7)
  42. Lin TY, Wu SW, Lin GM, Chen YG. Hidden Diagnosis of Tuberculous Pleurisy Masked by Concomitant Pseudomonas oryzihabitans Bacteremia. Respir Care. 2011 Jul 12. [Epub ahead of print] (SCI: IF: 2.0)
  43. Lin GM*, Li YH, Han CL. A critical appraisal of pexelizumab treatment in patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2011;142(2):472 (SCI, *corresponding author) (SCI: IF: 3.4)
  44. Lin GM*, Li YH. Hospital volume and processes, outcomes, and costs of care for congestive heart failure. Ann Intern Med. 2011;155(3):202 (SCI: IF: 16.7)
  45. Lin GM*, Tzeng BH. Ying and Yang of Tai-Chi Exercise. Arch Intern Med. 2011; 171: 1685 (SCI: IF: 11.0)
  46. Lin GM*. Pexelizumab, an Anti-C5 Complement Antibody for Primary Coronary Revascularization: A New Insight from Old Versions. Cardiovasc Hematol Disord Drug Targets 2011 Oct 26.
  47. Lin GM*, Chang FY, Chou CH, Lin YP, Ku CH*. Characteristics and Outcome of Patients With Dual Pulmonary Tuberculosis and Non-mycobacterial Respiratory Infections. J Clin Med Res. 2011; 3: 309-318.
  48. Lin GM, Chen YJ, Kuo DJ, Jaiteh LE, Wu YC, Lo TS, Li YH*. Cancer Incidence in Patients With Schizophrenia or Bipolar Disorder: A Nationwide Population-Based Study in Taiwan, 1997-2009. Schizophr Bull. 2011 Nov 1. [Epub ahead of print] (SCI: IF: 8.8)
  49. Lin GM*, Li YH, Jaiteh LE, Han CL. The risk of cardiovascular death associated with macrolide antibiotic use for acute lung injury. Int J Cardiol. 2012 Jul 12. [Epub ahead of print] (SCI: IF: 7.1)
  50. Lin GM*, Li YH, Jaiteh LE, Han CL. Warfarin may reduce risk of ischemic stroke by preventing atrial fibrillation for patients with heart failure and sinus rhythm. Int J Cardiol. 2012 Jul 12. [Epub ahead of print] (SCI: IF: 7.1)
  51. Lin GM*, Li YH, Jaiteh LE, Han CL. Role of yin and yang in diurnal blood pressure variation for cardiovascular disease. Hypertension. 2012 Sep;60(3):e27. (SCI: IF: 6.2)
  52. Lin GM*, Jaiteh LE, Han CL. Letter by Lin et al regarding article, "does body mass index impact on the relationship between systolic blood pressure and cardiovascular disease? Meta-analysis of 419 488 individuals from the Asia pacific cohort studies collaboration". Stroke. 2012 Oct;43(10):e105; (SCI: IF: 5.7)
  53. Lin GM*, Li YH*, Zheng NC, Lai CP, Lin CL, Wang JH, Jaiteh LE, Han CL. Serum uric acid as an independent predictor of mortality in high-risk patients with obstructive coronary artery disease: A prospective observational cohort study from the ET-CHD registry, 1997-2003. J Cardiol. 2012 Oct 19. doi:pii: S0914-5087(12)00239-0. 10.1016/j.jjcc.2012.09.004. [Epub ahead of print] (SCI: IF: 1.3)
  54. Lin GM*, Li YH, Jaiteh LE, Han CL. The obesity paradox of mortality in patients with coronary artery disease undergoing percutaneous coronary intervention. Int J Cardiol. 2012 Oct 23. doi:pii: S0167-5273(12)01339-3. 10.1016/j.ijcard.2012.09.216. [Epub ahead of print] (SCI: IF: 7.1)
  55. Lin GM*, Li YH, Jaiteh LE, Han CL. Pexelizumab fails to inhibit assembly of the terminal complement complex in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Insight from a substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. Am Heart J. 2012 Dec;164(6):e19. doi: 10.1016/j.ahj.2012.09.012. Epub 2012 Oct 29. (SCI: IF: 4.7)
  56. Lin GM*, Li YH, Jaiteh LE, Han CL. B-type natriuretic peptide level and postdischarge thrombotic events in older patients hospitalized with heart failure: Insights from the acute decompensated heart failure national registry. Am Heart J. 2013 Jan;165(1):e1. doi: 10.1016/j.ahj.2012.09.015. Epub 2012 Nov 20. (SCI: IF: 4.7)
  57. Lin GM*, Chen YJ, Li YH, Jaiteh LE, Han CL. The effect of hypoxia-hypercapnia on neuropsychological function in adult respiratory distress syndrome. Am J Respir Crit Care Med. 2012 Dec 15;186(12):1307. (SCI: IF: 11.0)
  58. Lin GM*, Li YH, Han CL. Treatment with clopidogrel after myocardial infarction. JAMA. 2012 Dec 19;308(23):2456-7. doi: 10.1001/jama.2012.28718. (SCI: IF: 30.0)
  59. Lin GM*, Li YH, Lin CL, Wang JH, Han CL. Relation of body mass index to mortality among Asian patients with obstructive coronary artery disease during a 10-year follow-up: a report from the ET-CHD registry. Int J Cardiol. 2013 Sep 20;168(1):616-20. doi: 10.1016/j.ijcard.2013.01.204. Epub 2013 Mar 7. (SCI: IF: 5.5)
  60. Lin GM*, Li YH, Lin CL, Wang JH, Han CL. Gender differences in the impact of diabetes on mortality in patients with established coronary artery disease: a report from the eastern Taiwan integrated health care delivery system of Coronary Heart Disease (ET-CHD) registry, 1997-2006. J Cardiol. 2013 Jun;61(6):393-8. doi: 10.1016/j.jjcc.2013.02.007. Epub 2013 Mar 15. (SCI: IF: 2.3)
  61. Lin GM*, Li YH, Han CL. Letter by Lin et al regarding article, "Dabigatran and thrombin modulate electrophysiological characteristics of pulmonary vein and left atrium" by Chang et al. Circ Arrhythm Electrophysiol. 2013 Apr;6(2):e22. (SCI: IF: 5.9)
  62. Chen YJ, Lin GM, Li YH. Cancer risk before schizophrenia diagnosis in Taiwan, 1995-2009. Schizophr Bull. 2013 Jul;39(4):729-31. (SCI: IF: 8.3)
  63. Lin GM*, Li YH, Lin CL, Wang JH, Han CL. Seasonal variation in cardiac death of patients with angiographic coronary artery disease from the ET-CHD registry, 1997-2006. Int J Cardiol. 2013 Oct 3;168(3):3090-2. (SCI: IF: 5.5)
  64. Lin GM*, Li YH, Han CL. Associations of inflammatory biomarkers to body mass index among patients with acute coronary syndrome. Int J Cardiol. 2013 Oct 3;168(3):3137-8. (SCI: IF: 5.5)
  65. Li YH, Lin GM*, Lin CL, Wang JH, Han CL. Relation of body mass index to mortality among patients with percutaneous coronary intervention longer than 5 years follow-up: A meta-analysis. Int J Cardiol. 2013 Oct 9;168(4):4315-8. (SCI: IF: 5.5)
  66. Lin GM*, Li YH, Lin CL, Wang JH, Han CL. Low high-density lipoprotein cholesterol and low/normal body mass index are associated with increased mortality in coronary artery disease patients in Taiwan. Circ J. 2013;77(8):2079-87. Epub 2013 May 16. (SCI: IF: 3.7)
  67. Li YH, Lin GM*, Lin CL, Wang JH, Han CL. Relation of estimated glomerular filtration rate and body mass index to mortality in non-dialysis patients with coronary artery disease: a report from the ET-CHD registry, 1997-2003. J Cardiol. 2013 Sep;62(3):144-50. (SCI: IF: 2.3)
  68. Li YH, Lin GM*, Lin CL, Wang JH, Chen YJ, Han CL. Relation of serum uric acid and body mass index to mortality in high-risk patients with established coronary artery disease: A report from the ET-CHD registry, 1997-2006. J Cardiol. 2013 Jul 6. doi:pii: S0914-5087(13)00184-6. 10.1016/j.jjcc.2013.06.002. [Epub ahead of print] (SCI: IF: 2.3)
  69. Li YH, Lin GM*, Lai CP, Lin CL, Wang JH. The "smoker's paradox" in Asian versus non-Asian patients with percutaneous coronary intervention longer than 6 months follow-up: A collaborative meta-analysis with the ET-CHD registry. Int J Cardiol. 2013 Oct 9;168(4):4544-8. (SCI: IF: 5.5)
  70. Li YH, Lin GM* Lai CP, Lin CL, Wang JH. β-Blocker use in angiographic coronary artery disease patients without myocardial infarction or heart failure: A report from the ET-CHD registry, 1997-2006. Int J Cardiol. 2013 Oct 12;168(5):4817-9. (SCI: IF: 5.5)
  71. Lin GM*, Li YH, Lin CL, Wang JH, Han CL. Relation of body mass index to bleeding events among patients with percutaneous coronary intervention: A meta-analysis. Int J Cardiol. 2013 Oct 12;168(5):4831-5. (SCI: IF: 5.5)
  72. Lin GM*, Li YH, Lin CL, Wang JH, Han CL. Relation of body mass index to mortality among patients with percutaneous coronary intervention in the drug-eluting stent era: A systematic review and meta-analysis. Int J Cardiol. 2013 Oct 9;168(4):4459-66. (SCI: IF: 5.5)
  73. Lin GM*, Li YH, Lin CL, Wang JH, Han CL. The "obesity-mortality paradox" phenomenon among Asian patients following percutaneous coronary artery intervention. J Cardiol. 2013 Sep 20. doi:pii: S0914-5087(13)00237-2. 10.1016/j.jjcc.2013.08.001. [Epub ahead of print] (SCI: IF: 2.3)
  74. Lin GM* The "obesity-mortality paradox" in severely traumatic patients in intensive care unit. Injury. 2013 Oct 26. doi:pii: S0020-1383(13)00487-7. 10.1016/j.injury.2013.10.023. [Epub ahead of print] (SCI: IF: 2.2)
  75. Lin GM.* Association between delayed heart rate recovery and incident hypertension: a revisit of CARDIA. Am J Hypertens. 2014 Jan; 27(1):140. (SCI: IF: 3.7)
  76. Lin GM.* The "obesity-mortality paradox" phenomenon in critically ill patients: one size does not fit all. Crit Care Med. 2014 Jan;42(1):e80-1. (SCI: IF: 6.1)
  77. Lin GM, Li YH.* Cancer risk among patients with hereditary muscular dystrophies: a population-based study in Taiwan, 1997-2009. Chin J Cancer. 2014 Jan 2. doi: 10.5732/cjc.013.10156.